Abstract
An oral pharmaceutical suspension has been one of the most favorable dosage forms for pediatric and geriatric patients or patients unable to tolerate solid dosage forms. The liquid form is preferred because of the ease of swallowing and flexibility in the administration of doses. This emerging area of suspensions as applied to the pharmaceutical field are discussed in the current article enlightening the vision of the readers towards pharmaceutical formulations including nanosuspensions, non-aqueous suspensions and modified release suspensions. The emphasis in the article focuses on the essential principles involved in the process of formation of different types of suspensions and their applications, since novel oral suspensions have potential to provide various strategy systems.
Keywords: Ion exchange resins, Microencapsulation, Modified release suspensions, Nanosuspensions, Non-aqueous suspensions, Ready to use.
Graphical Abstract
Current Drug Delivery
Title:Novel Oral Suspensions: A Review
Volume: 11 Issue: 3
Author(s): Harsha Kathpalia and Chetan Phadke
Affiliation:
Keywords: Ion exchange resins, Microencapsulation, Modified release suspensions, Nanosuspensions, Non-aqueous suspensions, Ready to use.
Abstract: An oral pharmaceutical suspension has been one of the most favorable dosage forms for pediatric and geriatric patients or patients unable to tolerate solid dosage forms. The liquid form is preferred because of the ease of swallowing and flexibility in the administration of doses. This emerging area of suspensions as applied to the pharmaceutical field are discussed in the current article enlightening the vision of the readers towards pharmaceutical formulations including nanosuspensions, non-aqueous suspensions and modified release suspensions. The emphasis in the article focuses on the essential principles involved in the process of formation of different types of suspensions and their applications, since novel oral suspensions have potential to provide various strategy systems.
Export Options
About this article
Cite this article as:
Kathpalia Harsha and Phadke Chetan, Novel Oral Suspensions: A Review, Current Drug Delivery 2014; 11 (3) . https://dx.doi.org/10.2174/1567201811666140113114926
DOI https://dx.doi.org/10.2174/1567201811666140113114926 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design Advances in the Physiology of GPR55 in the Central Nervous System
Current Neuropharmacology Implications of the Molecular Basis of Prostacyclin Biosynthesis and Signaling in Pharmaceutical Designs
Current Pharmaceutical Design Algorithm for the Construction of a Global Enzymatic Network to be used for Gene Network Reconstruction
Current Genomics Peripheral Mononuclear Cell Rejuvenation for Senescence Surveillance in Alzheimer Disease
Current Pharmaceutical Design Endothelin Receptors in Gastrointestinal Smooth Muscle
Current Protein & Peptide Science mTOR Inhibitors (Rapamycin and its Derivatives) and Nitrogen Containing Bisphosphonates: Bi-Functional Compounds for the Treatment of Bone Tumours
Current Medicinal Chemistry Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) In Vitro Analysis of Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis as a Possible Predictable Marker of TNF-alpha Blockers
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design Current Position on the Role of Monomeric C-reactive Protein in Vascular Pathology and Atherothrombosis
Current Pharmaceutical Design Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application
Current Pharmaceutical Design Lipoxygenases - A Challenging Problem in Enzyme Inhibition and Drug Development
Current Enzyme Inhibition Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Cardiovascular Toxicity from the Perspective of Oxidative Stress, Electron Transfer, and Prevention by Antioxidants
Current Vascular Pharmacology Subject Index to Volume 3
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Physiological and Pathological Functions of Acid-Sensing Ion Channels in the Central Nervous System
Current Drug Targets Novel Therapeutic Targets for Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
CNS & Neurological Disorders - Drug Targets